| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 9e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 5e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 6e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |